cyc 202 has been researched along with aldosterone in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (aldosterone) | Trials (aldosterone) | Recent Studies (post-2010) (aldosterone) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 25,333 | 1,517 | 4,169 |
| Protein | Taxonomy | cyc 202 (IC50) | aldosterone (IC50) |
|---|---|---|---|
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0048 | |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 0.043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, ND; Chakrabarti, M; Chrousos, GP; Jaffe, H; Kino, T; Pant, HC; Zheng, YL | 1 |
1 other study(ies) available for cyc 202 and aldosterone
| Article | Year |
|---|---|
Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor.
Topics: Aldosterone; Animals; Blotting, Western; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Cells, Cultured; Corticosterone; Cyclin-Dependent Kinase 5; Dexamethasone; Humans; Immunoprecipitation; Mass Spectrometry; Phosphorylation; Polymerase Chain Reaction; Purines; Rats; Receptors, Mineralocorticoid; Roscovitine; Two-Hybrid System Techniques | 2010 |